{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T23:23:58Z","timestamp":1771975438728,"version":"3.50.1"},"reference-count":29,"publisher":"Scientific Scholar","license":[{"start":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:00:00Z","timestamp":1588377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ruralneuropractice.com"],"crossmark-restriction":true},"short-container-title":["JNRP"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background<\/jats:bold>\u2003Thrombolysis improves the outcome in acute ischemic stroke (AIS), albeit with an increased risk of symptomatic intracranial hemorrhage (sICH). Biomarkers to find patients at risk of sICH, and guide treatment and prognosis would be valuable.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold>\u2003Consecutive patients of AIS thrombolysed between February 2017 and September 2019 at Calcutta National Medical College were studied prospectively for sICH and outcome at 6-month follow-up. We identified the independent risk factors for unfavorable outcomes, mortality, and sICH using multivariate analysis. Prethrombolysis and 24-hour postthrombolysis fibrinogen levels were estimated to evaluate its biomarker role.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold>\u2003Out of 180 AIS patients admitted during the study period, 60 patients were thrombolysed. Door to needle time was &lt;3 hours among 24 patients and 3 to 4.5 hours among 36 patients. Favorable outcomes occurred among 76.67% and sICH occurred among 13.33% patients. Upper tertile of National Institute of Health Stroke Scale (NIHSS) had the highest adjusted odds for sICH (17.5 [95% confidence intervals=1.7\u2013178.44]). Total anterior circulation stroke had the highest adjusted odds for unfavorable outcome (19.11 [3.9\u201392.6]). Following thrombolysis, the mean (standard deviation) fibrinogen level of 449.27 (32.87) decreased 7% to postthrombolysis level of 420 (20.5; p&lt; 0.0001). Higher tertiles of fibrinogen levels had progressively increasing odds for morbidity and sICH.<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold>\u2003Congestive heart failure, hypertension, age \u226575 years, diabetes mellitus, stroke (double weight), i.e., CHADS2 score &gt;2, low ejection fraction, the occurrence of total anterior circulation stroke and higher mean arterial blood pressure, blood glucose level, NIHSS score, and fibrinogen at admission were the common risk factors significantly predicting postthrombolysis sICH and morbidity. Antiplatelet and anticoagulant therapy, lower ASPECT (Alberta Stroke Program Early CT Score), and higher SEDAN scores also predicted sICH . Fibrinogen levels were significantly higher among those developing sICH and having unfavorable outcome. The performance of thrombolysis within 3 hours or between 3 and 4.5 hours after symptom onset did not affect morbidity, mortality, or the occurrence of sICH.<\/jats:p>","DOI":"10.1055\/s-0040-1709946","type":"journal-article","created":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T22:31:01Z","timestamp":1588458661000},"page":"315-324","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Predictors of Postthrombolysis Outcome and Symptomatic Postthrombolysis Hemorrhage following Intravenous Thrombolysis with Alteplase for Acute Ischemic Stroke"],"prefix":"10.25259","volume":"11","author":[{"given":"Suman","family":"Das","sequence":"first","affiliation":[{"name":"Department of Neurology, Calcutta National Medical College, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gourango Prosad","family":"Mondal","sequence":"additional","affiliation":[{"name":"Department of Neurology, Calcutta National Medical College, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Department of Neurology, Calcutta National Medical College, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kartick Chandra","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Neurology, Calcutta National Medical College, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarbajit","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Neurology, Calcutta National Medical College, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hema Krishna","family":"Pattem","sequence":"additional","affiliation":[{"name":"Department of Neurology, Calcutta National Medical College, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabir Ahmed","family":"Paul","sequence":"additional","affiliation":[{"name":"Department of Neurology, Calcutta National Medical College, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrakanta","family":"Patra","sequence":"additional","affiliation":[{"name":"Department of Neurology, Calcutta National Medical College, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2020,5,2]]},"reference":[{"key":"10.1055\/s-0040-1709946\/ref-1","first-page":"686797","article-title":"Barriers of thrombolysis therapy in developing countries","volume":"2011","author":"Ghandehari","year":"2011","journal-title":"Stroke Res Treat"},{"issue":"2","key":"10.1055\/s-0040-1709946\/ref-2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/ijmr.IJMR_516_15","article-title":"Incidence & prevalence of stroke in India: a systematic review","volume":"146","author":"Kamalakannan","year":"2017","journal-title":"Indian J Med Res"},{"issue":"3","key":"10.1055\/s-0040-1709946\/ref-3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.STR.28.3.491","article-title":"Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration","volume":"28","author":"Sudlow","year":"1997","journal-title":"Stroke"},{"issue":"2","key":"10.1055\/s-0040-1709946\/ref-4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5853\/jos.2016.01109","article-title":"Simple estimates of symptomatic intracranial hemorrhage risk and outcome after intravenous thrombolysis using age and stroke severity","volume":"19","author":"Lee","year":"2017","journal-title":"J Stroke"},{"issue":"9","key":"10.1055\/s-0040-1709946\/ref-5","doi-asserted-by":"crossref","first-page":"e0184646","DOI":"10.1371\/journal.pone.0184646","article-title":"Predictors of post-thrombolysis symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1055\/s-0040-1709946\/ref-6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4103\/aian.AIAN_228_17","article-title":"Predictors of intracerebral hemorrhage in acute stroke patients receiving intravenous recombinant tissue plasminogen activator","volume":"21","author":"Chenna","year":"2018","journal-title":"Ann Indian Acad Neurol"},{"issue":"3","key":"10.1055\/s-0040-1709946\/ref-7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s13311-011-0050-4","article-title":"Blood biomarkers of ischemic stroke","volume":"8","author":"Jickling","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1055\/s-0040-1709946\/ref-8","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/0140-6736(91)93206-O","article-title":"Classification and natural history of clinically identifiable subtypes of cerebral infarction","volume":"337","author":"Bamford","year":"1991","journal-title":"Lancet"},{"issue":"2","key":"10.1055\/s-0040-1709946\/ref-9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4103\/0972-2327.150592","article-title":"External validation of the SEDAN score: the real world practice of a single center","volume":"18","author":"Muengtaweepongsa","year":"2015","journal-title":"Ann Indian Acad Neurol"},{"issue":"5","key":"10.1055\/s-0040-1709946\/ref-10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000131083","article-title":"Guidelines for management of ischaemic stroke and transient ischaemic attack 2008","volume":"25","author":"European Stroke Organisation (ESO) Executive Committee","year":"2008","journal-title":"Cerebrovasc Dis"},{"issue":"8","key":"10.1055\/s-0040-1709946\/ref-11","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.07.043","article-title":"National survey of thrombolytic therapy for acute ischemic stroke in Taiwan 2003-2010","volume":"22","author":"Hsieh","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1055\/s-0040-1709946\/ref-12","doi-asserted-by":"crossref","first-page":"171S","DOI":"10.1177\/1076029618796317","article-title":"Predictive factors for functional outcomes after intravenous thrombolytic therapy in acute ischemic stroke","volume":"24","author":"\u00c7etiner","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"10.1055\/s-0040-1709946\/ref-13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12264-016-0019-8","article-title":"Factors associated with thrombolysis outcome in ischemic stroke patients with atrial fibrillation","volume":"32","author":"Zhao","year":"2016","journal-title":"Neurosci Bull"},{"issue":"24","key":"10.1055\/s-0040-1709946\/ref-14","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.3760\/cma.j.issn.0366-6999.20132354","article-title":"Factors influencing clinical outcomes of acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator","volume":"126","author":"Huang","year":"2013","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"10.1055\/s-0040-1709946\/ref-15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/01.STR.0000199851.24668.f1","article-title":"Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002","volume":"37","author":"Bateman","year":"2006","journal-title":"Stroke"},{"issue":"15","key":"10.1055\/s-0040-1709946\/ref-16","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.292.15.1831","article-title":"Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy","volume":"292","author":"Heuschmann","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1055\/s-0040-1709946\/ref-17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/0028-3886.30426","article-title":"Hyperacute thrombolysis with IV rtPA of acute ischemic stroke: efficacy and safety profile of 54 patients at a tertiary referral center in a developing country","volume":"55","author":"Padma","year":"2007","journal-title":"Neurol India"},{"issue":"4","key":"10.1055\/s-0040-1709946\/ref-18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/0972-2327.44556","article-title":"Hyperacute thrombolysis with recombinant tissue plasminogen activator of acute ischemic stroke: feasibility and effectivity from an Indian perspective","volume":"11","author":"Sharma","year":"2008","journal-title":"Ann Indian Acad Neurol"},{"issue":"10","key":"10.1055\/s-0040-1709946\/ref-19","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jocn.2009.01.004","article-title":"Intravenous thrombolysis for acute ischemic stroke: the Malabar experience 2003 to 2008","volume":"16","author":"Salam","year":"2009","journal-title":"J Clin Neurosci"},{"issue":"3","key":"10.1055\/s-0040-1709946\/ref-20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4103\/0028-3886.66085","article-title":"Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India","volume":"58","author":"Boddu","year":"2010","journal-title":"Neurol India"},{"issue":"9","key":"10.1055\/s-0040-1709946\/ref-21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1474-4422(16)30076-X","article-title":"Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis","volume":"15","author":"Whiteley","year":"2016","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1055\/s-0040-1709946\/ref-22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/hs0202.102599","article-title":"ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke","volume":"33","author":"Albers","year":"2002","journal-title":"Stroke"},{"issue":"3","key":"10.1055\/s-0040-1709946\/ref-23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4103\/aian.AIAN_323_18","article-title":"The risk of symptomatic intracranial hemorrhage after thrombolysis for acute stroke: current concepts and perspectives","volume":"22","author":"Modrego","year":"2019","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1055\/s-0040-1709946\/ref-24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3389\/fneur.2019.00513","article-title":"Markers of coagulation and fibrinolysis predicting the outcome of acute ischemic stroke thrombolysis treatment: a review of the literature","volume":"10","author":"Bagoly","year":"2019","journal-title":"Front Neurol"},{"issue":"12","key":"10.1055\/s-0040-1709946\/ref-25","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1161\/STROKEAHA.115.011290","article-title":"Coagulation and fibrinolytic activity of tenecteplase and alteplase in acute ischemic stroke","volume":"46","author":"Huang","year":"2015","journal-title":"Stroke"},{"issue":"3","key":"10.1055\/s-0040-1709946\/ref-26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000171704.50395.ba","article-title":"Hemostatic markers of recanalization in patients with ischemic stroke treated with rt-PA","volume":"65","author":"Mart\u00ed-F\u00e0bregas","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1055\/s-0040-1709946\/ref-27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbadis.2014.12.007","article-title":"Fibrinogen nitrotyrosination after ischemic stroke impairs thrombolysis and promotes neuronal death","volume":"1852","author":"Ill-Raga","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1055\/s-0040-1709946\/ref-28","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1523\/JNEUROSCI.22-10-03921.2002","article-title":"Influence of mild hypothermia on inducible nitric oxide synthase expression and reactive nitrogen production in experimental stroke and inflammation","volume":"22","author":"Han","year":"2002","journal-title":"J Neurosci"},{"issue":"23","key":"10.1055\/s-0040-1709946\/ref-29","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1523\/JNEUROSCI.17-23-09157.1997","article-title":"Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene","volume":"17","author":"Iadecola","year":"1997","journal-title":"J Neurosci"}],"container-title":["Journal of Neurosciences in Rural Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ruralneuropractice.com\/predictors-of-postthrombolysis-outcome-and-symptomatic-postthrombolysis-hemorrhage-following-intravenous-thrombolysis-with-alteplase-for-acute-ischemic-stroke\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ruralneuropractice.com\/predictors-of-postthrombolysis-outcome-and-symptomatic-postthrombolysis-hemorrhage-following-intravenous-thrombolysis-with-alteplase-for-acute-ischemic-stroke\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T02:44:02Z","timestamp":1722825842000},"score":1,"resource":{"primary":{"URL":"https:\/\/ruralneuropractice.com\/predictors-of-postthrombolysis-outcome-and-symptomatic-postthrombolysis-hemorrhage-following-intravenous-thrombolysis-with-alteplase-for-acute-ischemic-stroke\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,2]]},"references-count":29,"alternative-id":["10.1055\/s-0040-1709946"],"URL":"https:\/\/doi.org\/10.1055\/s-0040-1709946","relation":{},"ISSN":["0976-3147"],"issn-type":[{"value":"0976-3147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,2]]},"article-number":"315"}}